Fatal pneumonitis induced by oxaliplatin: Description of three cases

Case Reports in Oncology

Volumn 5, Issue 1, 2012, Pages 104-109

  Pontes, L B ^a   Armentano, D P D ^a   Soares, A ^a   Gansl, R C ^a  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

Drug induced toxicities; FOLFOX7m; Interstitial pneumonia; Oxaliplatin

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BEVACIZUMAB; CORTICOSTEROID; FLUOROURACIL; FOLINIC ACID; METHYLPREDNISOLONE; OSELTAMIVIR; OXALIPLATIN; PREDNISONE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ABNORMAL RESPIRATORY SOUND; AGED; ANEMIA; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GAS ANALYSIS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CANCER STAGING; CASE REPORT; CIGARETTE SMOKING; COLON ADENOCARCINOMA; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIABETES MELLITUS; DISEASE SEVERITY; DRUG WITHDRAWAL; DYSPEPSIA; DYSPNEA; EMPHYSEMA; FATALITY; FEMALE; HEMICOLECTOMY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HYPERCAPNIA; HYPERTENSION; HYPOXEMIA; INFLAMMATORY INFILTRATE; INTERSTITIAL PNEUMONIA; INTESTINE OBSTRUCTION; LIVER DISEASE; LIVER NODULE; LUNG AUSCULTATION; LUNG BIOPSY; LUNG FIBROSIS; LUNG INSUFFICIENCY; LUNG NODULE; LYMPHOCYTE; MALE; MULTIPLE CYCLE TREATMENT; NONINVASIVE VENTILATION; OXYGEN THERAPY; PHYSICAL EXAMINATION; PHYSICIAN; PRIORITY JOURNAL; RISK; SENSORY NEUROPATHY; SIDE EFFECT; SMOKING CESSATION; VOMITING; WEIGHT REDUCTION;

EID: 84860778884     PISSN: None     EISSN: 16626575     Source Type: Journal    
DOI: 10.1159/000337030     Document Type: Article

References (12)

1. Andre T, Boni C, Moudnedji-Boudiaf L, et al: Oxaliplatin, fluorouracil and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343-2351.
2. Ramanathan RK, Clark JW, Kemeny NE, et al: Safety and toxicity analysis of oxaliplatin combined with fluorouracil or as a single agent in patients with previously treated advanced colorectal cancer. J Clin Oncol 2003;21:2904-2911.
3. Lobera SA, Marinelarena NS, Echeberría IE, et al: Fatal pneumonitis induced by oxaliplatin. Clin Transl Oncol 2008;10:764-767.
4. Jeanfaivre T, Saint-Andre JP, Tuchais E: Fibrose pulmonaire aigue au decors d'un traitement par fluorouracile et cisplatine. Therapie 1995;50:167-169.
5. Pasetto LM, Monfardini S: Is acute dyspnea related to oxaliplatin administration? World J Gastroenterol 2006;12:5907-5908.
6. Yagüe XH, Soy E, Marino BQ, et al: Interstitial pneumonitis after oxaliplatin treatment in colorectal cancer. Clin Transl Oncol 2005;7:515-517.
7. Garrido M, O'Brien A, González S, et al: Cryptogenetic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: case report. Chest 2007;132:1997-1999.
8. Wilcox BE, Ryu JH, Kalra S: Exacerbation of pre-existing interstitial lung disease after oxaliplatin therapy: a report of three cases. Respir Med 2008;102:273-279.
9. Rubbia-Brandt L, Audard V, Sartoretti P, et al: Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004;15:460-466.
10. Muneoka K, Shirai Y, Sasaki M, et al: Interstitial pneumonia arising in a patient treated with oxaliplatin, 5-fluorouracil, and, leucovorin (FOLFOX). Int J Clin Oncol 2009;14:457-459.
11. Andou H, Itoh K, Tsuda T: A case of fluorouracil-induced pneumonitis. Nihon Kyoubu Shikkan Gakkai Zasshi 1999;35:1080-1083.
12. Gagnadoux F, Roiron C, Carrie E, et al: Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer. Am J Clin Oncol 2002;25:388-390.